MOLECUBES NV

⭐️ This was #EANM24! We shifted standards with Bruker Preclinical Imaging and #Pmod in Hamburg. Thank you to all who visited us at our booth and to all our experts who were present there to showcase our newest innovations in hardware, software, and workflow!    🎬 We’re excited to share the highlights with you through our after-movie. Check it out to relive the best moments of the conference and our social event!    Looking forward to #EANM25 in Barcelona next year, from 4 to 8 November!   #PreclinicalImaging European Association of Nuclear Medicine (EANM)

It's the last day of #EANM24! Come and stop by booth H10, hall H, to see how we are shifting standards and pushing the limits in collaboration, efficiency, and quality control! There is still time to meet our experts and to look at our new and improved CUBEFLOW.   Also, be sure to check out the abstracts and posters from some of our customers:   👉 OP-651: 123/125Iodine labelled-PARP inhibitor-loaded polymeric micelles for combination radio-chemotherapy against triple-negative breast cancer - RWTH Aachen University   👉 OP-671: Discovery of [177Lu]Lu-EVS459, a novel low-molecular weight radioligand therapy for the treatment of folate receptor positive cancers - Novartis Pharma Services AG   👉OP-727: In vivo detection of C. difficile infection by immunoPET imaging using toxin-selective radiotracers - CNIC - Spanish National Center for Cardiovascular Research / Centro Nac. Investigaciones Cardiovasc.   👉 OP-785: Selective PET imaging using the Al18F-labeled CXCR4 antagonist LY2510924: “Al18F-NOTA-SC, the new kid on the block - KU Leuven   Can't make it? Visit the link below to learn all about our new CUBEFLOW.   #PreclinicalImaging European Association of Nuclear Medicine (EANM) Bruker Preclinical Imaging #PMOD 

EANM day 2!   💡 At #EANM24 and curious to learn more? Be sure to check out the talk from University Hospital Basel, presented by F. De Rose: Development of an Innovative 61Cu/67Cu Platform for Theranostic Solutions in Oncology: from Discovery to Clinical Trials!   🔎 You can follow the talk during the M2M Track - From Radionuclide to Clinical Translation on Tuesday, 22/10, starting at 08:00!   Want to read more about this research? Be sure to check out the research paper from Dr. Tais Basaco Bernabeu et al. - 61Cu-PSMA–Targeted PET for Prostate Cancer: From Radiotracer Development to First-in-Human Imaging. In this research paper, the B-CUBE has been used as a dynamic PET scanning tool to study the in vivo biodistribution of 61CU-labeled tracers.   👉 Read more via the link below!   #PreclinicalImaging #PET #Oncology European Association of Nuclear Medicine (EANM)

⭐️ We're at the European Association of Nuclear Medicine (EANM) conference in Hamburg, shifting the standards in collaboration, efficiency, and quality control.   Come visit us at booth H10, Hall H, with Bruker Preclinical Imaging and #PMOD.   Be sure to stop by and see our new CUBEFLOW in action! Our experts, Kim, Sam, Etlir, Robin, Katarzyna, Andrea, Geoff, Afroditi, and Dr. Michael Heidenreich will answer all your questions about our latest innovations in hardware, software, and workflow.   Also, be sure to check out the following abstracts and posters featuring our CUBES:   Sunday: 👉OP-016: PET Evaluation of Oligonucleotide Structural Effects on Tumor Targeting in HCC1954 Breast Cancer Xenografts - T. Auchynnikava from Turun yliopisto - University of Turku   Monday: 👉 OP-343: One for all: core-radiolabeled nanomaterial as a platform for multimodal imaging and therapy - F. Herranz from CIC biomaGUNE   Can't make it? Visit the link here to learn all about our new CUBEFLOW. 💡 https://lnkd.in/eQcy8mnw   #ShiftingStandards #EANM24 #CUBEFLOW #PreclinicalImaging

  ⭐️ Why should you visit us at #EANM24? This video shows you why!   Come join MOLECUBES with Bruker Preclinical Imaging and #PMOD in Hamburg, October 19-23!   Visit our booth to see how we are pushing the limits in collaboration, efficiency, and quality control with the latest software, workflow, and hardware advancements.   Meet our experts - Katarzyna, Robin, Kim, Sam, and Etlir - to learn more about our advances in animal monitoring or improved CUBEFLOW, or stop by the booth to take a look!   📍 Where to find us? Hall H, Booth H10. 💡 Can’t wait? Visit the link here for an exclusive first look at the new CUBEFLOW! 👉 https://lnkd.in/eQcy8mnw     #ShiftingStandards #EANM24 #CUBEFLOW #PreclinicalImaging

💡 Cube-user Loren Deblock is one of the finalists of the Flemish PhD Cup! During his doctorate, he developed a new contrast agent in close collaboration with radiologists and surgeons to improve the surgical treatment of breast cancer patients. This new contrast agent, made from nanocrystals, can visualize the sentinel lymph node before and during surgery using CT and fluorescence. These imaging techniques can work cheaper, more accessible, faster, and more accurately than current methods.   Every year, more than 2 million women are diagnosed with breast cancer, making it the most common cancer in the world. Therefore, research into better imaging and therapies is crucial so that these patients can receive the best possible treatment. 🎗️   👉 More information? Read more via the link below (Dutch) The final takes place on October 16. Good luck, Loren!   #PhDCup2024 #BreastCancerAwareness #PreclinicalImaging Ghent University

We are launching our new CUBEFLOW, designed to maximize your lab’s productivity!   It’s our mission to improve accessibility to nuclear molecular imaging technologies, which is why we are connecting the dots with our new workflow so you can make the most out of your expertise and increase the speed and quality of your research.   With CUBEFLOW, we are shifting standards in: ✅ Quality Control: Reproducible, consistent performance over time, supported by straightforward, automated procedures. 📈 Efficiency: Focus on your core tasks and do more research with the same resources. Less hassle, more focus. 🤝 Collaboration: Collaborate more efficiently with and between teams through study standardization and planning.   Watch the video below on how we are shifting standards through our new and improved workflow.   Want to see CUBEFLOW in action? Visit us at the European Association of Nuclear Medicine (EANM) conference with Bruker Preclinical Imaging and #PMOD to see it live!   💡 For more information: https://lnkd.in/eQcy8mnw   #PreclinicalImaging #CUBEFLOW #EANM2024

🎀🎗️October marks Breast Cancer Awareness Month!     MOLECUBES proudly supports Breast Cancer Awareness Month and those affected by breast cancer. Breast Cancer Awareness Month is an international health campaign held every October. The month aims to promote screening and prevention of the disease, which affects millions globally. This month, we will share inspiring and innovative research concerning preclinical imaging research in breast cancer.   In this post, we will highlight the groundbreaking research of two of our customers, whose work is making significant strides in the fight against breast cancer. Their work will also be presented at the upcoming European Association of Nuclear Medicine (EANM) conference.   🔬L. Schäfer - Department of Nuclear Medicine, University Hospital Aachen (Uniklinik RWTH Aachen) Abstract: OP-651: 123/125 Iodine labelled-PARP inhibitor-loaded polymeric micelles for combination radio-chemotherapy against triple-negative breast cancer.   In this study, SPECT/CT was used to investigate in vivo biodistribution and therapeutic efficacy of the radio-nanoformulation. In vivo SPECT/CT measurements revealed prolonged circulation, higher tumor accumulation, and decelerated deiodination of the tracer encapsulated in micelles compared to the naked tracer.   🔬 T. Auchynnikava - Turku PET Centre and the Department of Chemistry, Turun yliopisto - University of Turku Abstract: OP-016: PET Evaluation of Oligonucleotide Structural Effects on Tumor Targeting in HCC1954 Breast Cancer Xenografts.   Positron emission tomography (PET) is a valuable tool for developing novel therapeutics. In this study, In vivo PET/CT was used to investigate and evaluate the structural effects of oligonucleotides on tumor targeting in breast cancer xenografts. The developed radiolabeled method allowed us to successfully demonstrate the beneficial properties of MSNAs over linear ON and to study the structural effects on biodistribution.   💡Read more about their research via the abstract excerpts below!    #BreastCancerAwareness #PreclinicalImaging #EANM2024

  🎥 Behind The Scenes: Workflow Video Shoot!   🔎 We have been working on exciting new content that will be coming your way soon! Take a look behind the scenes of our latest video shoot for our new workflow video, showcasing our newest software.   Thank you to our movie stars—Etlir, Hannah, and Milan for your enthusiasm and to Bram Ryde for filming! And a huge shoutout to Kim for her stellar coordination and organization!   💡 We'll be launching the new workflow video soon. Stay tuned!   #BehindTheScenes #CUBEFLOW #ShiftingStandards

MOLECUBES is heading to the European Association of Nuclear Medicine (EANM) in Hamburg from October 19 to 23!   Join us to see how Bruker, MOLECUBES, and #PMOD push the limits in collaboration, efficiency, and quality control with the latest software, workflow, and hardware improvements.   Meet our experts—Katarzyna, Robin, Kim, Sam, and Etlir—to learn more about our advances in animal monitoring and workflow, or stop by the booth to see our new software in action!   📍 Where to find us? Hall H, Booth H10. See you there!   💡 Can’t wait? Visit the link below for an exclusive first look at the new CUBEFLOW!   #ShiftingStandards #EANM24 #CUBEFLOW #PreclinicalImaging Bruker BioSpin Bruker Preclinical Imaging